Understanding the Market | Chunli Medical rose over 10%, turning a profit of 77.0619 million yuan in the third quarter as the company actively expands its international market business

CHUNLI MEDICAL's stock price rose by more than 10%, with an increase of 10.66% as of the time of publication, reported at HKD 18.37, with a transaction volume of HKD 45.461 million. The company released its performance for the first three quarters of 2025, with operating revenue of 756 million yuan, a year-on-year increase of 48.75%; net profit attributable to the parent company of 192 million yuan, a year-on-year increase of 213.21%. In the third quarter, it achieved operating revenue of 268 million yuan, a year-on-year increase of 109.51%; net profit attributable to the parent company of 77.0619 million yuan, turning a profit. Huatai Securities pointed out that the company is actively expanding its international market, with rapid growth in overseas revenue, which has become an important source of income